Janelle I.

Janelle I. has extensive work experience in drug safety and pharmacovigilance. Janelle is currently the Director of Global Drug Safety Operations and Compliance at Cerevel Therapeutics. Prior to this, they held roles at various pharmaceutical companies, including the Parker Institute for Cancer Immunotherapy, where they served as Director and Associate Director of Patient Safety and Pharmacovigilance. Janelle also worked as a Senior Manager of Pharmacovigilance at Clovis Oncology, Drug Safety Manager at Medivation, Drug Safety Specialist and Associate at Pharmacyclics, and Drug Safety Associate at Onyx Pharmaceuticals. Additionally, they held positions as a Drug Safety Assistant at InterMune, Drug Safety Coordinator at Actelion, and Administrative Coordinator at Genentech. Janelle I. has been working in this field since 2009 and has gained valuable experience in drug safety operations, compliance, and coordination.

Janelle I. pursued their education by obtaining a Bachelor of Arts degree in Business Management Economics from the University of California, Santa Cruz from 2005 to 2008. Janelle then continued their educational journey at the University of California, Riverside in 2004-2005. Janelle I. further expanded their knowledge and skills by completing a Master of Public Health (MPH) degree at A.T. Still University of Health Sciences from 2017 to 2019.